Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted ...
Advair is used to treat asthma and chronic obstructive pulmonary disease. The Association for Accessible Medicines is voicing strong opposition that the proposed U.S.-Mexico-Canada trade agreement ...
1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline. 2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults. 3. Imbruvica in ...
A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...
LONDON (Reuters) - Hikma and its partner Vectura are in dispute with the Food and Drug Administration over their plans to launch a generic copy of GlaxoSmithKline's popular lung drug Advair in the U.S ...
LONDON (Reuters) - GlaxoSmithKline Plc's top-selling lung drug Advair is set to enjoy a longer lease of life than widely expected, due to the difficulties facing generic companies seeking to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results